Treatment of HER2-positive breast cancer: looking backwards briefly

Lancet Oncol. 2013 Dec;14(13):1250-1. doi: 10.1016/S1470-2045(13)70536-9. Epub 2013 Nov 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / drug therapy*
  • Female
  • Humans
  • Mastectomy*
  • Neoadjuvant Therapy / methods*
  • Receptor, ErbB-2 / analysis*

Substances

  • Biomarkers, Tumor
  • ERBB2 protein, human
  • Receptor, ErbB-2